Author:
Liu Huan,Qiu Yikai,Pei Xiuying,Chitteti Ramamurthy,Steiner Rebbeca,Zhang Shuya,Jin Zheng Gen
Abstract
AbstractAngiogenesis is a physiological process for the formation of new blood vessels from the pre-existing vessels and it has a vital role in the survival and growth of neoplasms. During tumor angiogenesis, the activation of the gene transcriptions in vascular endothelial cells (ECs) plays an essential role in the promotion of EC proliferation, migration, and vascular network development. However, the molecular mechanisms underlying transcriptional regulation of EC and tumor angiogenesis remains to be fully elucidated. Here we report that the transcription factor Yin Yang 1 (YY1) in ECs is critically involved in tumor angiogenesis. First, we utilized a tamoxifen-inducible EC-specific YY1 deficient mouse model and showed that YY1 deletion in ECs inhibited the tumor growth and tumor angiogenesis. Using the in vivo matrigel plug assay, we then found that EC-specific YY1 ablation inhibited growth factor-induced angiogenesis. Furthermore, vascular endothelial growth factor (VEGF)-induced EC migration was diminished in YY1-depleted human umbilical vein endothelial cells (HUVECs). Finally, a rescue experiment revealed that YY1-regulated BMP6 expression in ECs was involved in EC migration. Collectively, our results demonstrate that endothelial YY1 has a crucial role in tumor angiogenesis and suggest that targeting endothelial YY1 could be a potential therapeutic strategy for cancer treatment.
Funder
National Natural Science Foundation of China
West China first-class Disciplines Basic Medical Sciences at Ningxia Medical University
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Peterson, H.-I. Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors (CRC Press, Boca Raton, 2020).
2. Chouaib, S. et al. Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit. Rev. Immunol. 30, 529–545 (2010).
3. Margariti, A. et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc. Natl. Acad. Sci. 109, 13793–13798 (2012).
4. De Palma, M. & Naldini, L. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim. Biophys. Acta (BBA) Rev. Cancer 1766, 159–166 (2006).
5. Herkenne, S. et al. Developmental and tumor angiogenesis requires the mitochondria-shaping protein opa1. Cell Metab. https://doi.org/10.1016/j.cmet.2020.04.007 (2020).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献